Hepatitis C co-infection characteristics and correlates in newly reported HIV/AIDS patients in Southwest China, 2018-2022

被引:0
作者
Zhang, Yulian [1 ]
Jike, Chunnong [2 ]
Yu, Gang [2 ]
Wang, Ju [2 ]
Wang, Zhonghong [2 ]
Ma, Lazuo [2 ]
Li, Tianlu [2 ]
Li, Yuan [1 ]
Pei, Rong [1 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Publ Hlth, Chengdu, Sichuan, Peoples R China
[2] Liangshan Prefecture Ctr Dis Control & Prevent, Xichang, Sichuan, Peoples R China
来源
JOURNAL OF PUBLIC HEALTH-HEIDELBERG | 2023年 / 33卷 / 5期
关键词
HIV/AIDS; HCV; co-infection; Correlative factor; TREATMENT OUTCOMES; VIRAL-HEPATITIS; ALCOHOL-USE; HIV; BURDEN; VIRUS; HCV; COHORT;
D O I
10.1007/s10389-023-02095-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
AimsThe aims of the project were: (1) to map the current HIV-HCV co-infection in Liangshan Prefecture, Sichuan Province, China, (2) to explore the risk factors of HIV-HCV co-infection in Liangshan Prefecture, and (3) to propose strategies for prevention and control of HIV-HCV co-infection in Liangshan Prefecture.Subject and methodsThis study assessed the HIV-HCV co-infection rate, characteristics, and correlative factors of HIV-HCV co-infection individuals reported between 2018 and 2022 in Liangshan. This made use of path analysis, multiple logistic regression analysis, and chi-square tests.ResultsThe findings revealed a 6.75% HIV-HCV co-infection rate, and the incidence was stable from 2018 to 2022. The outcomes of multiple logistic regression showed the correlative factors, including male (OR = 2.640, 95% CI: 2.300-3.031), 25-44 years (OR = 4.184, 95% CI: 2.135-8.196), 45-64 years (OR = 3.411, 95% CI: 1.733-0.937), Anning River Valley (OR = 2.583, 95% CI: 1.833-3.639) and east of it (OR = 2.543, 95% CI: 1.749-3.699), and injecting drug use (OR = 2.116, 95% CI: 1.879-2.383). The pathway analysis revealed that co-infection was directly influenced by gender (-0.112), ethnicity (-0.079), marital status (0.077), and route of infection (-0.095).ConclusionConcentrate on the high-risk group based on the co-infection associated factors found in the study's findings. Take the necessary steps to enhance patient quality of life and survival, as well as the efficacy of preventive treatment and therapy.
引用
收藏
页码:1027 / 1035
页数:9
相关论文
共 38 条
  • [1] HIV-HCV Coinfection: Prevalence and Treatment Outcomes in Malaysia
    Akhtar, Ali
    Fatima, Samreen
    Saeed, Hamid
    Soo, Chow Ting
    Khan, Amer Hayat
    [J]. INTERVIROLOGY, 2022, 65 (02) : 87 - 93
  • [2] Epidemiology of viral hepatitis and HIV co-infection
    Alter, MJ
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S6 - S9
  • [3] A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
    Azar, Marwan M.
    Springer, Sandra A.
    Meyer, Jaimie P.
    Altice, Frederick L.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2010, 112 (03) : 178 - 193
  • [4] Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal
    Bhattarai, Manjula
    Baniya, Jagat Bahadur
    Aryal, Nirmal
    Shrestha, Bimal
    Rauniyar, Ramanuj
    Adhikari, Anurag
    Koirala, Pratik
    Oli, Pardip Kumar
    Pandit, Ram Deo
    Stein, David A.
    Gupta, Birendra Prasad
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [5] Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)
    Carrieri, Maria Patrizia
    Serfaty, Lawrence
    Vilotitch, Antoine
    Winnock, Maria
    Poizot-Martin, Isabelle
    Loko, Marc-Arthur
    Lions, Caroline
    Lascoux-Combe, Caroline
    Roux, Perrine
    Salmon-Ceron, Dominique
    Spire, Bruno
    Dabis, Francois
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (01) : 40 - 48
  • [6] Chen Xu Chen Xu, 2020, Journal of Clinical Hepatology, V36, P88
  • [7] Chinese Center for Disease Control and Prevention, 2021, General situation of notifiable infectious diseases in China in 2020
  • [8] Chinese Center for Disease Control and Prevention, 2022, LEAD WAY AIDS PREV A
  • [9] Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
    Cooke, Graham S.
    Andrieux-Meyer, Isabelle
    Applegate, Tanya L.
    Atun, Rifat
    Burry, Jessica R.
    Cheinquer, Hugo
    Dusheiko, Geoff
    Feld, Jordan J.
    Gore, Charles
    Griswold, Max G.
    Hamid, Saeed
    Hellard, Margaret E.
    Hou, JinLin
    Howell, Jess
    Jia, Jidong
    Kravchenko, Natalia
    Lazarus, Jeffrey V.
    Lemoine, Maud
    Lesi, Olufunmilayo A.
    Maistat, Liudmyla
    McMahon, Brian J.
    Razavi, Homie
    Roberts, Teri R.
    Simmons, Bryony
    Sonderup, Mark W.
    Spearman, C. Wendy
    Taylor, Bridie E.
    Thomas, David L.
    Waked, Imam
    Ward, John W.
    Wiktor, Stefan Z.
    Abdo, Ayman
    Aggarwal, Rakesh
    Aghemo, Alessio
    Al-Judaibi, Bandar
    Al Mahtab, Mamun
    Altaf, Arshad
    Ameen, Zyaad
    Asselah, Tarik
    Baatarkkhuu, Oidov
    Barber, Ella
    Barnes, Eleanor
    Boulet, Pascale
    Burrows, Louise
    Butsashvili, Maia
    Chan, Erica
    Chow, Chelsea
    Cowie, Ben
    Cunningham, Chris
    de Araujo, Alexandre
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (02): : 135 - 184
  • [10] Danhui Y, 2008, Structural equation modeling: methods and applications, P4